| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.ARCMED.2013.07.001 |
| P698 | PubMed publication ID | 23871709 |
| P2093 | author name string | Wei Wei | |
| Cheng Chen | |||
| Guang Yan | |||
| Ting-ting Hu | |||
| Shi-lian Hu | |||
| Wei-ping Xu | |||
| Jing-mo Yang | |||
| Ting-juan Xu | |||
| P433 | issue | 5 | |
| P921 | main subject | meta-analysis | Q815382 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 380-389 | |
| P577 | publication date | 2013-07-16 | |
| P1433 | published in | Archives of Medical Research | Q15751494 |
| P1476 | title | Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis | |
| P478 | volume | 44 |
| Q33670896 | Activation of EGFR and ERBB2 by Helicobacter pylori results in survival of gastric epithelial cells with DNA damage |
| Q26774528 | Advanced gastric cancer: What we know and what we still have to learn |
| Q90609239 | Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy |
| Q38691748 | An independent survival prognostic role for human epidermal growth factor receptor 2 in gastric cancer: evidence from a meta-analysis |
| Q37269090 | Associations between serum CA724 and HER2 overexpression among stage II-III resectable gastric cancer patients: an observational study |
| Q35716215 | Clinicopathologic and molecular features associated with patient age in gastric cancer |
| Q40332121 | Clinicopathologic and prognostic significance of human epidermal growth factor receptor in patients with gastric cancer: An updated meta-analysis |
| Q34954681 | Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer |
| Q31112933 | Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients |
| Q40256327 | Distinct prognostic values of YAP1 in gastric cancer |
| Q92073891 | Epidermal Growth Factor Receptor Family and its Role in Gastric Cancer |
| Q30372977 | Exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers. |
| Q53091400 | Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma. |
| Q36547753 | Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma |
| Q36807851 | Expression of APPL1 is correlated with clinicopathologic characteristics and poor prognosis in patients with gastric cancer |
| Q28082921 | From molecular classification to targeted therapeutics: the changing face of systemic therapy in metastatic gastroesophageal cancer |
| Q26780318 | HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach |
| Q28078111 | HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists |
| Q35029025 | HER2 expression in gastric and oesophageal cancer: a meta-analytic review |
| Q87469034 | HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides |
| Q35211263 | HER2 in solid tumors: more than 10 years under the microscope; where are we now? |
| Q54312070 | HER2 testing in malignant effusions of metastatic gastric carcinoma: is it feasible? |
| Q55359616 | Optimal management of resected gastric cancer. |
| Q26774521 | Personalized medicine in gastric cancer: Where are we and where are we going? |
| Q35623711 | Plasma membrane proteomic analysis of human Gastric Cancer tissues: revealing flotillin 1 as a marker for Gastric Cancer |
| Q38687568 | Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers |
| Q92073923 | Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence |
| Q26769034 | Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis |
| Q43479667 | Prognostic significance of HER2 expression based on trastuzumab for gastric cancer (ToGA) criteria in gastric cancer: an updated meta-analysis |
| Q34308255 | Single nucleotide polymorphisms in AREG and EREG are prognostic biomarkers in locally advanced gastric cancer patients after surgery with curative intent. |
| Q37655585 | State of the art in anti-cancer mAbs. |
| Q26779217 | State of the art management of metastatic gastroesophageal cancer |
| Q38364292 | Targeted therapy in gastric cancer |
| Q55069791 | The NanoString-based multigene assay as a novel platform to screen EGFR, HER2, and MET in patients with advanced gastric cancer. |
| Q99712042 | The Role of HER2 in Self-Renewal, Invasion, and Tumorigenicity of Gastric Cancer Stem Cells |
| Q42265610 | The relative efficacy and safety of targeted agents used in combination with chemotherapy in treating patients with untreated advanced gastric cancer: a network meta-analysis |
Search more.